Development of Emerging Modalities: Challenges and Strategies.
| Published in: | BioPharm International Vol. 39; no. 2; pp. 6 - 10 |
|---|---|
| Main Author: | |
| Format: | pictorial questions and answers Journal Article |
| Published: |
MJH Life Sciences
Mar/Apr2026
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193002078&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 193002078 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Mar/Apr2026 vid: 39 iid: 2 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 193002078 193002078 193002078 193002078 ppf: 6 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Development of Emerging Modalities: Challenges and Strategies. aug: au: CHALLENER, CYNTHIA A. affil: BioPharm International sug: subj: Drug Development Methods Biological Products Diffusion of Innovation Quality Control (Technology) Gene Therapy Gene Editing Nanoparticles Uncertainty United States Food and Drug Administration Disease Vectors Nucleic Acids Therapeutic Use pubtype: Trade Publication doctype: pictorial questions and answers Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|